MDNA - Medicenna Therapeutics GAAP EPS of -$0.07 in-line
- Medicenna Therapeutics press release ( NASDAQ: MDNA ): Q1 GAAP EPS of -$0.07 in-line.
- Medicenna had cash, cash equivalents, and marketable securities of $19.3 million at June 30, 2022, compared to $20.5 million at March 31, 2022.
For further details see:
Medicenna Therapeutics GAAP EPS of -$0.07 in-line